These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1553336)

  • 1. An experimental design strategy for quantitating complex pharmacokinetic models: enterohepatic circulation with time-varying gallbladder emptying as an example.
    Wang YM; Reuning RH
    Pharm Res; 1992 Feb; 9(2):169-77. PubMed ID: 1553336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Gallbladder-Based Enterohepatic Circulation Model for Pharmacokinetic Studies.
    Okour M; Brundage RC
    Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):493-504. PubMed ID: 30488336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mean residence time for drugs subject to enterohepatic cycling.
    Shepard TA; Lockwood GF; Aarons LJ; Abrahams ID
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):327-45. PubMed ID: 2810071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man.
    Hofmann AF; Molino G; Milanese M; Belforte G
    J Clin Invest; 1983 Apr; 71(4):1003-22. PubMed ID: 6682120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency of enterohepatic circulation, its determination and influence on drug bioavailability.
    Horkovics-Kovats S
    Arzneimittelforschung; 1999 Oct; 49(10):805-15. PubMed ID: 10554656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptotics and bioavailability in multicompartment pharmacokinetic models with enterohepatic circulation.
    Horkovics-Kovats S; Zlatos P
    Math Biosci; 2003 Jul; 184(1):69-99. PubMed ID: 12788234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor activity of the gallbladder and gastrointestinal tract as determinants of enterohepatic circulation. A scintigraphic and manometric study.
    Qvist N
    Dan Med Bull; 1995 Nov; 42(5):426-40. PubMed ID: 8747800
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism-based enterohepatic circulation model of mycophenolic acid and its glucuronide metabolite: assessment of impact of cyclosporine dose in Asian renal transplant patients.
    Yau WP; Vathsala A; Lou HX; Zhou S; Chan E
    J Clin Pharmacol; 2009 Jun; 49(6):684-99. PubMed ID: 19386625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model systems for pharmacokinetics of steroid drugs subject to enterohepatic circulation.
    Schumann W; Hillesheim HG; Gira G
    Exp Clin Endocrinol; 1986 Jul; 87(2):118-24. PubMed ID: 3758191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptotics and bioavailability in a 17-compartment pharmacokinetic model with enterohepatic circulation and remetabolization.
    Horkovics-Kovats S; Zlatos P
    Math Biosci; 2006 Sep; 203(1):19-36. PubMed ID: 16616213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure.
    Okour M; Jacobson PA; Ahmed MA; Israni AK; Brundage RC
    J Clin Pharmacol; 2018 May; 58(5):628-639. PubMed ID: 29329489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the population pharmacokinetics and the enterohepatic recirculation of total ezetimibe.
    Soulele K; Karalis V
    Xenobiotica; 2019 Apr; 49(4):446-456. PubMed ID: 29629619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug recirculation model with multiple cycles occurring at unequal time intervals.
    Plusquellec Y; Houin G
    J Biomed Eng; 1992 Nov; 14(6):521-6. PubMed ID: 1434577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of the effective amount entering the body for drugs subject to enterohepatic recirculations.
    Plusquellec Y; Houin G
    Med Eng Phys; 1995 Apr; 17(3):172-6. PubMed ID: 7795853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference.
    Moriwaki T; Yasui H; Yamamoto A
    J Pharmacokinet Pharmacodyn; 2003 Apr; 30(2):119-44. PubMed ID: 12942684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of enterohepatic recirculation in drug disposition: cooperation and complications.
    Malik MY; Jaiswal S; Sharma A; Shukla M; Lal J
    Drug Metab Rev; 2016 May; 48(2):281-327. PubMed ID: 26987379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic model for analysis of drug disposition profiles undergoing enterohepatic circulation.
    Wajima T; Yano Y; Oguma T
    J Pharm Pharmacol; 2002 Jul; 54(7):929-34. PubMed ID: 12162711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats.
    Huntjens DR; Strougo A; Chain A; Metcalf A; Summerfield S; Spalding DJ; Danhof M; Della Pasqua O
    Br J Pharmacol; 2008 Mar; 153(5):1072-84. PubMed ID: 18193075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the Change in the Blood Concentration-Time Profile Caused by Complex Drug-Drug Interactions in the Liver Considering the Enterohepatic Circulation: Examining Whether the Inhibition Constants for Uptake, Metabolism, and Biliary Excretion Can be Recovered by the Analyses Using Physiologically Based Pharmacokinetic Modeling.
    Toshimoto K; Tomoda Y; Chiba K; Sugiyama Y
    J Pharm Sci; 2017 Sep; 106(9):2727-2738. PubMed ID: 28479365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model-Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans.
    Guiastrennec B; Sonne DP; Bergstrand M; Vilsbøll T; Knop FK; Karlsson MO
    CPT Pharmacometrics Syst Pharmacol; 2018 Sep; 7(9):603-612. PubMed ID: 30070437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.